|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,940.00 GBX | -3.34% |
|
+1.81% | +6.33% |
| 07:29pm | GSK, Relation Therapeutics to Collaborate on Human Cellular Perturbation Data | MT |
| 05:00pm | GSK : Deutsche Bank gives a Neutral rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 106B | |||||
| 1,079B | |||||
| 640B | |||||
| 465B | |||||
| 353B | |||||
| 301B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
